Searched for
POTENTOX
Venus Remedies eyes tie-ups for out-licensing drugsVenus Remedies Ltd has targeted a turnover of Rs 1000 crore by FY'18, even as it eyes partners in Europe and US for out licensing drugs.- Venus Remedies gets European patent for antibiotic drugThe product is designed for mixed multi-drug infections for pediatric, geriatric and adult immuno-compromised patients.
- Venus eyes Rs 1,000 crore revenue by FY 2017Venus Remedies aims to launch its major products in global markets with an eye on more than doubling revenues to Rs 1,000 cr by 2016-17.
- Sensex under pressure; top ten stocks in actionSensex came under pressure in mid-morning trade, as investors preferred to stay on sidelines. Take a look at ten stocks which are in focus.
- Venus Remedies shares rally 10% on Mexico patent for PotentoxVenus Remedies shares rallied nearly 10% in morning trade, after the company received patent from Mexico for its novel antibiotic Potentox.
- Ten stocks in focus in Tuesday morning tradeIndian markets are likely to trade in a range. Here is a list of ten stocks which are likely to remain in focus in morning trade.
- Venus Remedies gets Mexico patent for PotentoxGranted by the Mexican Institute of Industrial Property, the patent protects the composition of Potentox, the company said.
- Venus gets US patent for antibiotic productVenus Remedies has got US patent for Potentox, used for pneumonia other infections and is looking at increasing presence in the $ 12 bn ant...
- Venus Remedies gets Australian patent approval for VancoplusDrug firm Venus Remedies today said it has received approval from the Australian Patent office (APO) for its product 'Vancoplus'.
- Venus Remedies gets GMP accreditation from SudanPharmaceutical company Venus Remedies on Tuesday said that seven units at its Baddi plant in Himachal Pradesh have received the Good Manufa...
Load More
